We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VALMT:OMXHEXValmet Corp Analysis

Data as of 2026-03-11 - not real-time

€27.19

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Valmet is trading below its short‑ and long‑term moving averages, with a neutral trend and a bearish MACD histogram that suggests short‑term pressure. The RSI sits near the mid‑40s, indicating neither overbought nor oversold conditions, while volatility is elevated and beta remains low, pointing to a stock that moves sharply but is less correlated with the market. A strong dividend yield near five percent and a payout ratio close to ninety percent are supported by robust operating cash flow and free cash flow generation. Valuation metrics show a price‑to‑earnings multiple well under the industry average and a discounted cash‑flow fair value that implies modest upside, reinforcing the view that the stock is undervalued relative to peers. Recent earnings releases highlighted record EBITA margins and solid cash flow, underscoring operational strength.
Analyst consensus remains a buy with target prices above the current level, and the high dividend coupled with low beta suggests an attractive risk‑adjusted return for income‑focused investors. While market sentiment is extremely greedy, the combination of low leverage, diversified geographic exposure, and industry tailwinds in automation and sustainability supports a positive outlook across medium and long horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and proximity to support level
  • Elevated short‑term volatility
  • Attractive dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to DCF fair value and peer PE
  • Strong cash flow and record EBITA margins
  • Analyst buy consensus with target above current price

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Secular growth in automation and sustainability solutions
  • Stable, high dividend supported by free cash flow
  • Low beta and diversified global footprint reducing market risk

Key Metrics & Analysis

Financial Health

Revenue Growth-3.30%
Profit Margin5.39%
P/E Ratio17.9
ROE10.76%
ROA4.97%
Debt/Equity56.41
P/B Ratio1.9
Op. Cash Flow€581.0M
Free Cash Flow€496.5M
Industry P/E29.3

Technical Analysis

TrendNeutral
RSI44.1
Support€26.00
Resistance€29.41
MA 20€27.70
MA 50€28.46
MA 200€28.44
MACDBearish
VolumeIncreasing
Fear & Greed Index78.16

Valuation

Fair Value€32.37
Target Price€29.40
Upside/Downside8.13%
GradeUndervalued
TypeBlend
Dividend Yield4.99%

Risk Assessment

Beta0.39
Volatility38.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.